These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 36013483

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, Yang Z, Zhang Y, Wang C, Wang Y, Zuo D, Li B, Yuan Y.
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [Abstract] [Full Text] [Related]

  • 23. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Liu K, Zheng H, Sui X, Liu B, Meng M, Feng Y, Zhu Q, Zhao X.
    Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
    [Abstract] [Full Text] [Related]

  • 24. Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria.
    Zhang L, Yin X, Gan YH, Zhang BH, Zhang JB, Chen Y, Xie XY, Ge NL, Wang YH, Ye SL, Ren ZG.
    BMC Gastroenterol; 2014 Jan 10; 14():11. PubMed ID: 24410841
    [Abstract] [Full Text] [Related]

  • 25. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM, Titano JJ, Bishay VL, Durrani RJ, Dayan E, Tabori N, Patel RS, Nowakowski FS, Fischman AM, Kim E.
    Radiology; 2017 Jun 10; 283(3):895-905. PubMed ID: 27930089
    [Abstract] [Full Text] [Related]

  • 26. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L, Ke Q, Lin N, Huang Q, Zeng Y, Liu J.
    Int J Hyperthermia; 2019 Jun 10; 36(1):1288-1296. PubMed ID: 31852267
    [Abstract] [Full Text] [Related]

  • 27. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R, Shen L, Zhao L, Guan Z, Chen Q, Li W.
    Diagn Interv Radiol; 2018 Jul 10; 24(4):219-224. PubMed ID: 29792289
    [Abstract] [Full Text] [Related]

  • 28. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ.
    Chin J Cancer; 2017 Jan 19; 36(1):14. PubMed ID: 28103953
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
    Kaibori M, Yoshii K, Hasegawa K, Ogawa A, Kubo S, Tateishi R, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N, Liver Cancer Study Group of Japan.
    Ann Surg; 2019 Jul 19; 270(1):121-130. PubMed ID: 29608544
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X, Yu H, Zhao F, Xu Y, Wang C, Liu K, Liu B, Zheng H, Wei Y, Wang X, Zhu Q, Huang M, Feng Y.
    Eur J Radiol; 2023 Jul 19; 164():110860. PubMed ID: 37178491
    [Abstract] [Full Text] [Related]

  • 34. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm.
    Zaitoun MMA, Elsayed SB, Zaitoun NA, Soliman RK, Elmokadem AH, Farag AA, Amer M, Hendi AM, Mahmoud NEM, Salah El Deen D, Alsowey AM, Shahin S, Basha MAA.
    Int J Hyperthermia; 2021 Jul 19; 38(1):248-256. PubMed ID: 33615957
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.
    Korean J Intern Med; 2016 Mar 19; 31(2):242-52. PubMed ID: 26874512
    [Abstract] [Full Text] [Related]

  • 38. Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value.
    Liu J, Zhang W, Lu H, Li H, Zhou X, Li J, Han X.
    J Cancer Res Clin Oncol; 2022 Jul 19; 148(7):1781-1788. PubMed ID: 34405295
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM, Lai CX, Zuo MX, An C, Wang XC, Huang JH, Ning E.
    J Cancer Res Ther; 2020 Jul 19; 16(7):1603-1610. PubMed ID: 33565506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.